Integrating activation-induced costimulation and cytokine signals enhance TCR-based cell therapies
NARULA, M.; Englisch, J.; Ou, C.; Honda, T.; San Sebastian, I. d. l. I.; Arnett, A. B.; Mo, F.; Mamonkin, M.; Watanabe, N.
Show abstract
TCR-based cell therapies offer broad targeting of tumor antigens with high sensitivity but often low durability due to insufficient costimulation (signal 2) and cytokine (signal 3) support. To address this, we developed a dual stimulatory receptor (DSR) consisting of the 4-1BBL ectodomain fused to the thrombopoietin receptor (cMPL) endodomain. DSR engages 4-1BB that is transiently upregulated upon TCR stimulation eliciting signal 2 and simultaneously activates cMPL-driven STAT3/5 phosphorylation providing signal 3. DSR increases the expansion of T cells, preserving their effector function and an effector-associated transcriptional profile upon repeated antigen stimulation. DSR arming significantly improves in vivo antitumor activity of T cells redirected to cancer through engineered TCRs or soluble T-cell engagers in diverse xenograft tumor models by enhancing T cell expansion and persistence post-infusion. These results demonstrate broad utility and establish DSR as a modular receptor for the effective and synchronized delivery of signals 2 and 3 to support TCR-based immunotherapies.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- LAG-3 blockade reactivates the CD8+ T cell expansion program to re-expand contracted clones in the tumor 97%
- Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma 97%
- Combinatorial immunotherapies overcome MYC-driven immune evasion 97%
Similar papers in this journal
- Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunity 97%
- SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8 T cells 97%
- NFAT5 induction by the tumor microenvironment enforces CD8 T cell exhaustion 97%
Similar papers in this journal
- Quality of vaccination-induced T cell responses is conveyed by polyclonality and high, but not maximum, antigen receptor avidity 98%
- Distinct CD8+ T Cell Programming in the Tumor Microenvironment Contributes to Sex Bias in Bladder Cancer Outcome 97%
- Asparagine availability controls B cell homeostasis 96%
Similar papers in this journal
- Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance 96%
- Chromatin conformation dynamics during CD4+ T cell activation implicates autoimmune disease-associated genes and regulatory elements 96%
- Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy 95%
Similar papers in this journal
- IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy 98%
- Soluble CTLA-4 mainly produced by Treg cells inhibits type 1 inflammation without hindering type 2 immunity to allow for inflammation resolution 97%
- Functional impairment of "helpless" CD8+ memory T cells is transient and driven by prolonged but finite cognate antigen presentation 97%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.